Literature DB >> 10896349

Novel imaging techniques for diabetic macular edema.

C Lobo1, R Bernardes, J R Faria de Abreu, J G Cunha-Vaz.   

Abstract

Retinal edema should be defined as any increase of water of the retinal tissue resulting in an increase in its volume. It may be of cytotoxic or vasogenic origin. Development of vasogenic macular edema is dependent on a series of factors such as blood pressure, blood-retinal barrier permeability, retinal cell damage, retinal tissue osmotic pressure and retinal tissue compliance. Objective measurements of retinal thickness are now possible using the Retinal Thickness Analyser. Localised measurements of blood-retinal barrier permeability may also be obtained using the Retinal Leakage Analyser, a modified confocal scanning laser fluorometer, while obtaining simultaneously angiographic images of the choroid and retina. These new imaging techniques show that cytotoxic and vasogenic retinal edema may occur independently in the early stages of diabetic retinopathy. These findings offer new perspectives for designing novel therapeutic strategies.

Entities:  

Mesh:

Year:  1999        PMID: 10896349     DOI: 10.1023/a:1002479823690

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  6 in total

1.  Feasibility test of a new method to measure retinal thickness noninvasively.

Authors:  R C Zeimer; M T Mori; B Khoobehi
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-10       Impact factor: 4.799

2.  Imaging of macular diseases with optical coherence tomography.

Authors:  C A Puliafito; M R Hee; C P Lin; E Reichel; J S Schuman; J S Duker; J A Izatt; E A Swanson; J G Fujimoto
Journal:  Ophthalmology       Date:  1995-02       Impact factor: 12.079

Review 3.  Breakdown of the blood-retinal barriers and cystoid macular edema.

Authors:  J G Cunha-Vaz; A Travassos
Journal:  Surv Ophthalmol       Date:  1984-05       Impact factor: 6.048

4.  Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.

Authors:  J A Corbett; R G Tilton; K Chang; K S Hasan; Y Ido; J L Wang; M A Sweetland; J R Lancaster; J R Williamson; M L McDaniel
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

5.  Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy.

Authors:  M K Van den Enden; J R Nyengaard; E Ostrow; J H Burgan; J R Williamson
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-07       Impact factor: 4.799

6.  Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.

Authors:  H H Parving; M Larsen; E Hommel; H Lund-Andersen
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

  6 in total
  3 in total

1.  Intravitreal bevacizumab alone versus combined with macular photocoagulation in diabetic macular edema.

Authors:  Soo Jeong Lee; Ei Tae Kim; Yeon Sung Moon
Journal:  Korean J Ophthalmol       Date:  2011-09-20

Review 2.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

3.  Communications between intraretinal and subretinal space on optical coherence tomography of neurosensory retinal detachment in diabetic macular edema.

Authors:  Aditi Gupta; Rajiv Raman; Kp Mohana; Vaitheeswaran Kulothungan; Tarun Sharma
Journal:  Oman J Ophthalmol       Date:  2013-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.